LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 2 of 15: Cell count and relative growth within biological replicate 2. - Dataset (ID:20238)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Foretinib | 0.37 | uM | LJP5 | 2 | H10 | 72 | hr | 2543 | 2670 | 5578 | 0.4786 | 0.0417 |
| SK-BR-3 | Foretinib | 0.37 | uM | LJP5 | 3 | H10 | 72 | hr | 2543 | 2617 | 5578 | 0.4691 | 0.0242 |
| SK-BR-3 | R406 | 0.37 | uM | LJP6 | 1 | C16 | 72 | hr | 2543 | 5116 | 5578 | 0.9171 | 0.8476 |
| SK-BR-3 | R406 | 0.37 | uM | LJP6 | 2 | C16 | 72 | hr | 2543 | 5500 | 5578 | 0.9859 | 0.9741 |
| SK-BR-3 | R406 | 0.37 | uM | LJP6 | 3 | C16 | 72 | hr | 2543 | 5342 | 5578 | 0.9576 | 0.9220 |
| SK-BR-3 | Pictilisib | 0.37 | uM | LJP6 | 1 | D22 | 72 | hr | 2543 | 2473 | 5578 | 0.4433 | -0.0232 |
| SK-BR-3 | Pictilisib | 0.37 | uM | LJP6 | 2 | D22 | 72 | hr | 2543 | 2593 | 5578 | 0.4648 | 0.0163 |
| SK-BR-3 | Pictilisib | 0.37 | uM | LJP6 | 3 | D22 | 72 | hr | 2543 | 2720 | 5578 | 0.4876 | 0.0582 |
| SK-BR-3 | Gefitinib | 0.37 | uM | LJP6 | 1 | N10 | 72 | hr | 2543 | 3442 | 5578 | 0.6170 | 0.2960 |
| SK-BR-3 | Gefitinib | 0.37 | uM | LJP6 | 2 | N10 | 72 | hr | 2543 | 4183 | 5578 | 0.7498 | 0.5402 |
| SK-BR-3 | Gefitinib | 0.37 | uM | LJP6 | 3 | N10 | 72 | hr | 2543 | 4621 | 5578 | 0.8283 | 0.6845 |
| SK-BR-3 | Geldanamycin | 0.37 | uM | LJP5 | 1 | O04 | 72 | hr | 2543 | 2101 | 5578 | 0.3766 | -0.1458 |
| SK-BR-3 | Geldanamycin | 0.37 | uM | LJP5 | 2 | O04 | 72 | hr | 2543 | 2089 | 5578 | 0.3745 | -0.1497 |
| SK-BR-3 | Geldanamycin | 0.37 | uM | LJP5 | 3 | O04 | 72 | hr | 2543 | 2307 | 5578 | 0.4135 | -0.0779 |
| SK-BR-3 | Geldanamycin | 0.37 | uM | LJP6 | 1 | O04 | 72 | hr | 2543 | 2170 | 5578 | 0.3890 | -0.1230 |
| SK-BR-3 | Geldanamycin | 0.37 | uM | LJP6 | 2 | O04 | 72 | hr | 2543 | 2014 | 5578 | 0.3610 | -0.1744 |
| SK-BR-3 | Geldanamycin | 0.37 | uM | LJP6 | 3 | O04 | 72 | hr | 2543 | 2012 | 5578 | 0.3607 | -0.1751 |
| SK-BR-3 | GSK1059615 | 0.37 | uM | LJP5 | 1 | E04 | 72 | hr | 2543 | 4668 | 5578 | 0.8368 | 0.7000 |
| SK-BR-3 | GSK1059615 | 0.37 | uM | LJP5 | 2 | E04 | 72 | hr | 2543 | 4901 | 5578 | 0.8785 | 0.7767 |
| SK-BR-3 | GSK1059615 | 0.37 | uM | LJP5 | 3 | E04 | 72 | hr | 2543 | 4995 | 5578 | 0.8954 | 0.8077 |
| SK-BR-3 | GSK1059615 | 0.37 | uM | LJP6 | 1 | C04 | 72 | hr | 2543 | 3433 | 5578 | 0.6154 | 0.2931 |
| SK-BR-3 | GSK1059615 | 0.37 | uM | LJP6 | 2 | C04 | 72 | hr | 2543 | 3465 | 5578 | 0.6211 | 0.3036 |
| SK-BR-3 | GSK1059615 | 0.37 | uM | LJP6 | 3 | C04 | 72 | hr | 2543 | 3517 | 5578 | 0.6304 | 0.3208 |
| SK-BR-3 | GSK1904529A | 0.37 | uM | LJP6 | 1 | H22 | 72 | hr | 2543 | 5495 | 5578 | 0.9850 | 0.9724 |
| SK-BR-3 | GSK1904529A | 0.37 | uM | LJP6 | 2 | H22 | 72 | hr | 2543 | 5337 | 5578 | 0.9567 | 0.9204 |